PMID: 7960599Jan 1, 1994Paper

Multidrug resistance in cancer chemotherapy

Investigational New Drugs
N H Patel, M L Rothenberg

Abstract

Resistance to chemotherapy is the single most important reason for treatment failure in cancer patients. Over the past 15 years, we have gained significant insight into one of the mechanisms responsible for this process: multidrug resistance (MDR). Far from being a phenomenon limited to the laboratory, multidrug resistance has been identified in a wide variety of newly diagnosed and recurrent human tumors. A number of compounds can block p-glycoprotein and overcome MDR in vitro and in vivo. Current strategies to block MDR are discussed in this review. Future research in this area will focus on the identification of more selective and potent MDR reversing agents and the development of entirely new approaches to overcoming multidrug resistance such as monoclonal antibodies, immunotoxins, and gene therapy.

References

Nov 11, 1976·Biochimica Et Biophysica Acta·R L Juliano, V Ling
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·G F FlemingA R Safa
May 6, 1992·Journal of the National Cancer Institute·C E HerzogA Fojo
Aug 1, 1992·Diseases of the Colon and Rectum·T J SaclaridesR S Weinstein
Aug 4, 1992·Biochemical Pharmacology·C CuvierM F Poupon
Sep 16, 1992·Biochemical and Biophysical Research Communications·A R ThierryA Rahman
Sep 1, 1992·Annals of Hematology·M I TiirikainenT Krusius
Nov 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E SolaryH Guy
Jan 1, 1992·Journal of Cancer Research and Clinical Oncology·B Jandrig, V Wunderlich
May 1, 1992·Mutation Research·I B Roninson
Sep 1, 1992·Gynecologic Oncology·J MäenpääM Grönroos
Oct 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A M YahandaB I Sikic
Oct 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B L LumB I Sikic
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·C P VendrikP A Steerenberg
May 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K V SpeegD Muirhead
Mar 1, 1992·Irish Medical Journal·D J Hehir, D M Phelan
Jan 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G ToffoliM Boiocchi
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·A Ramu, N Ramu
Jul 1, 1992·British Journal of Cancer·D M WoodcockW H Sawyer
Jan 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·G H MickischI Pastan
Jan 1, 1991·Journal of Cancer Research and Clinical Oncology·B FuchsL Suter
Aug 1, 1991·British Journal of Cancer·M FavrotC Bailly
Oct 2, 1991·Journal of the National Cancer Institute·W T Beck
Dec 5, 1991·The New England Journal of Medicine·H S ChanV Ling
Dec 1, 1991·British Journal of Cancer·D BissettS B Kaye
Jan 16, 1991·Journal of the National Cancer Institute·G D PennockS E Salmon
May 15, 1991·Journal of the National Cancer Institute·M R Baer, C D Bloomfield
Apr 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M Chatterjee, A L Harris
Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A FojoI Pastan
Sep 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M W DeGregorioV J Wiebe
Jan 18, 1989·Journal of the National Cancer Institute·L J GoldsteinG M Brodeur
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C Cordon-CardoJ R Bertino
Feb 15, 1989·Biochemical and Biophysical Research Communications·M NaitoT Tsuruo
Apr 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W S DaltonS E Salmon
Mar 1, 1989·Scientific American·N Kartner, V Ling

Citations

Jan 1, 1996·Breast Cancer Research and Treatment·M TerenzianiG Bonadonna
Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P M Ravdin
Jun 13, 2002·Il Farmaco·E TeodoriF Gualtieri
May 8, 1998·Obstetrics and Gynecology·G Coukos, S C Rubin
Oct 10, 2012·Endocrine-related Cancer·Francesmary ModugnoSteffi Oesterreich
Sep 28, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Chen-Hsi HsiehYu-Jen Chen
Nov 22, 2005·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·B BonavidaT Miki
Dec 14, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Bertrand CaillierBenoit Drolet
Feb 24, 2009·Journal of Molecular and Cellular Cardiology·Raymond HreicheBenoit Drolet
May 20, 2014·Immunologic Research·Kawther K AhmedAliasger K Salem
Jan 10, 1997·Biochemical Pharmacology·J F PouliotE Georges
May 1, 1996·Cancer Treatment Reviews·S Joel
Mar 7, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Changhan LeeValter D Longo
May 29, 2008·Administration and Policy in Mental Health·Amy M KilbourneFrederic C Blow
Jan 1, 1997·Biopolymers·Y QianA D Hamilton
Mar 7, 1997·The Journal of Biological Chemistry·M DemeuleR Béliveau
Jun 25, 2014·Oncology Letters·Ying LiuZhengqiu Zhu
Jun 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R A PeckM J Hawkins
Apr 1, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Wenjie WangYa Ding

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.